Some of the most widely used prescription drugs, including those to treat cholesterol and high blood pressure, could be available over the counter under a new proposal being weighed by government regulators.
A new drug for diabetics is expected to improve the treatment of high levels of chronic kidney disease in Indigenous communities.
U.S. drug regulators may fine Merck for failing to test whether its diabetes drugs Januvia and Janumet can raise the risk of an inflamed pancreas, according to a warning letter posted online on Tuesday.
U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, to indicate that they may raise levels of blood sugar and could cause memory loss.
Can a shot make you skinny? A new injection is changing the lives of diabetes patients — by changing their waistlines.
A novel agent that activates a free fatty acid receptor successfully increased insulin secretion without raising the risk of hypoglycemia in patients with type 2 diabetes, a randomized study found.
An experimental drug improves patients’ blood sugar control without increasing the risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, according to the results of a phase 2 clinical trial.
Phase 2 clinical data of an investigational type 2 diabetes therapy, TAK-875 of Takeda Pharmaceutical Company Limited (“Takeda”), were published online first in The Lancet.
Victoza seems to work by turning off appetite. Another diabetes drug — Byetta — has similar results. Could someone who’s not diabetic use the shot to drop pounds?
Sirona Biochem, a biotechnology company, has announced that SBM-TFC-039, significantly and rapidly reduced the blood glucose level in obese diabetic rats.
In 80 percent of diabetic patients treated with this novel drug, blood glucose levels normalized within days – a change that’s not attributed to weight loss.
The American College of Physicians issued a Clinical Practice Guideline for diabetic patients who need to add a drug treatment to control blood sugar levels.
Pharmaceutical companies are developing a pill containing a biodegradable chip along with the medication to send information on patient’s vital statistics to a smartphone.
The Resolute clinical trial program enrolled more than 5,000 patients worldwide, a third of whom had diabetes.
A recent analysis has found that cancer patients with diabetes who were on Metformin monotherapy have a significantly reduced overall mortality compared with cancer patients without diabetes.
Johnson & Johnson’s anti-psychotic drug Risperdal wasn’t a substantial factor in causing a Nebraska man’s diabetes.
The Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion in the European Union for the expanded use of BYETTA® as an add-on therapy to basal insulin.
The American Diabetes Association’s established that patients just diagnosed with type 2 diabetes should start taking metformin right away
The US Drug Watchdog says that they need the help of family members, and loved ones of diabetics who now have bladder cancer to ask the diabetic if they were using the diabetes drug called Actos, prior to being diagnosed with bladders cancer.
Novo’s Victoza is the leading drug in the GLP-1 analogue class, a relatively new class of injectable drugs which adds to the existing choices of oral treatments and short and long-acting insulin products.